# Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study

> **NCT06053203** · — · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 1200 (actual)

## Conditions studied

- Hypertensive Disorders of Pregnancy

## Interventions

- **OTHER:** Exposure of interest - Moderate or High-risk Preeclampsia

## Key facts

- **NCT ID:** NCT06053203
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-31
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-11-30
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06053203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06053203, "Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06053203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*